Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection [0.03%]
HIV-1原发感染的病毒学和免疫学特征——包括有症状与无症状感染者
D R Henrard,E Daar,H Farzadegan et al.
D R Henrard et al.
To define virologic and immunologic differences in patients with acute symptomatic and asymptomatic primary human immunodeficiency virus type 1 (HIV-1) infection, sequential plasma specimens were obtained longitudinally for 1-2 years postse...
Incubation period of vertically acquired AIDS in Europe before widespread use of prophylactic therapies [0.03%]
预防疗法广泛使用前欧洲垂直感染艾滋病的潜伏期
A M Downs,G Salamina,R A Ancelle-Park
A M Downs
European surveillance data on vertically acquired (VA) AIDS cases were used to investigate the incubation period of AIDS in the absence of widespread prophylactic treatment and to assess the uncertainty associated with parametric estimates ...
Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes [0.03%]
近期感染人类免疫缺陷病毒及可能迅速丧失CD4T淋巴细胞计数
S D Holmberg,L J Conley,S P Luby et al.
S D Holmberg et al.
To assess a hypothesized trend that persons recently infected with the human immunodeficiency virus (HIV) may have more rapid declines in absolute CD4 T-lymphocyte (CD4+ cell) counts than those who were HIV-infected in earlier years, sequen...
Score cards for AIDS care [0.03%]
艾滋病治疗积分表
C L Bennett,B R Cassileth,J A DeHovitz et al.
C L Bennett et al.
Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia [0.03%]
临床试验新药治疗卡氏肺孢子虫肺炎的临床经验报告
A White,S LaFon,M Rogers et al.
A White et al.
The clinical experience of human immunodeficiency virus (HIV) + patients treated with oral atovaquone for acute Pneumocytstis carinii pneumonia (PCP) under a Treatment Investigational New Drug (IND) protocol (mild or moderate PCP) and an Op...
A phase I evaluation of concomitant rifabutin and didanosine in symptomatic HIV-infected patients [0.03%]
关于利福丁与叠氮胸苷联用的I期临床评价研究
J Sahai,P K Narang,N Hawley-Foss et al.
J Sahai et al.
It has been suggested that didanosine (ddI) may undergo hepatic metabolism. Rifabutin is an inducer of drug metabolism. Fifteen human immunodeficiency virus-infected patients whose conditions were stabilized on twice-daily doses of ddI part...
Clinical evaluation of Amplicor HIV-1 test for detection of human immunodeficiency virus type 1 proviral DNA in peripheral blood mononuclear cells [0.03%]
Amplicor HIV-1检测法鉴定外周血单个核细胞中人免疫缺陷病毒1型原病毒DNA的临床评估
A Khadir,F Coutlée,P Saint-Antoine et al.
A Khadir et al.
We report here the clinical evaluation of Amplicor polymerase chain reaction (PCR) assay for the detection of the human immunodeficiency virus type 1 (HIV-1) in peripheral blood mononuclear cells (PBMCs). Results obtained with Amplicor HIV-...
The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study [0.03%]
齐多夫定治疗的HIV感染者血浆病毒载量的预后价值：为期两年的随访研究
A Ruffault,C Michelet,C Jacquelinet et al.
A Ruffault et al.
To determine the prognostic value of plasma viremia in long-term zidovudine (AZT)-treated HIV-infected patients, HIV-1 plasma viremia (PV) was quantified in 28 HIV-infected patients before and during AZT long-term treatment; the follow-up a...
A prospective study of mother-to-infant HIV transmission in tribal women from India [0.03%]
印度部落妇女母婴HIV传播的前瞻性研究
R M Kumar,S A Uduman,A K Khurranna
R M Kumar
The transmission of human immunodeficiency virus type 1 from infected mothers to their babies was assessed by serologic, virologic, and clinical means. Of the 160 antibody-positive women enrolled at the beginning of the study, 13 had overt ...
Multiple superinfections fail to activate defective human immunodeficiency virus-1 (HIV-1) infection of rabbits [0.03%]
多重复染未能激活兔的缺陷型人类免疫缺陷病毒(HIV-1)感染
S Sell,C K Tseng
S Sell
Superinfection of human immunodeficiency virus (HIV)-1-infected rabbits with Treponema pallidum, Mycobacterium avium, herpes simplex, Candida albicans, Mycoplama incognitus, and malignant catarrhal fever virus, as well as irradiation or cor...